FDA Medical Device Recalls (openFDA)
Meridian Bioscience Inc: Revogene RNA Software Upgrade Kit Revogene RNA Software Upgrade USBs Catalog Number: 610240 IVD used to install the Revogene System Software version 4.2.0, import the Revogene Instrument Control Protocol file for RNA-based assay, and install the Assay Definition File (ADF) file
- Recall number
- Z-1541-2021
- Recalling firm
- Meridian Bioscience Inc
- Product
- Revogene RNA Software Upgrade Kit Revogene RNA Software Upgrade USBs Catalog Number: 610240 IVD used to install the Revogene System Software version 4.2.0, import the Revogene Instrument Control Protocol file for RNA-based assay, and install the Assay Definition File (ADF) file
- Status
- Terminated
- Initiated
- 2021-04-08
- Posted
- not on file
- Terminated
- 2021-10-26
- Reason
- Emergency Use Application (EUA) application withdrawn as false negative results reported
- Root cause
- Under Investigation by firm
- Action
- Meridan issued Urgent Medical Device Recall on 4/08/21 to the user level via phone and electronic mailing . Letter states reason for recall, health risk and action to take: Revogene SARS-CoV-2, Catalog 410700: Laboratorys should consider evaluating patient test results per laboratory policies and procedures. Review current inventory and segregate any remaining stock. Contact Meridian Technical Support 800.343.3858 to obtain a FedEx label to return any remaining unexpired inventory to Meridian Bioscience Inc. Any expired inventory should be destroyed in accordance with facility protocols. Complete and return the Customer Notification Form. This will indicate receipt of this field correction notice. Revogene RNA Software Upgrade Kit, Catalog 610240: Review current inventory and segregate any remaining stock of the RNA Software kit, including the USB. Contact Meridian Technical Support 800.343.3858 to obtain a FedEx label to return remaining unexpired inventory to Meridian Bioscience, Inc. Any expired inventory should be destroyed in accordance with facility protocols. Complete and return the Customer Notification Form. This will indicate receipt of this field correction notice. Actions to Be Taken By Meridian: Meridian intends to conduct additional validation and bridging studies with the intention of re-submitting an EUA application for its SARS-CoV-2 test on the Revogene platform as soon as possible thereafter. Contact Information: If you have any questions, please call Meridian Bioscience Technical Services at 1-800-343-3858, or email at MBI-TechService@meridianbioscience.com.
- Quantity
- 124 Revogene RNA Software Upgrade Kits
- Distribution
- Nationwide
- Lot, serial or model codes
- All lot numbers
- 510(k) numbers
- not on file
- PMA numbers
- not on file
- Product code
- QJR
- Firm FEI
- 1524213
- Firm city
- Cincinnati
- Firm state
- OH
- Firm country
- not on file
Where this comes from
- Register
- FDA Medical Device Recalls (openFDA)
- Publisher
- U.S. Food and Drug Administration (openFDA)
- File
- device-recall-0001-of-0001.json.zip
- sha256
- b87518bfe2e8
- Size
- 288210821 bytes
- Published
- 2026-09-28
- Read
- 2026-09-29T08:25:23.626Z
- Source file
- Source file retained · verify
- Refresh due
- 2026-10-06
Unless otherwise noted, the content, data, documentation, code, and related materials on openFDA is public domain and made available with a Creative Commons CC0 1.0 Universal dedication.
Cite as
FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28